(ANSA) - BRUSSELS, JAN 12 - Oral antivirals such as Paxlovide, intravenously, such as Remdesivir "maintain their effectiveness against Omicron and can help limit the burden of disease associated with this variant".
This was stated by the head of the vaccination strategy of the European Medicines Agency (EMA), Marco Cavaleri, at a press conference.
(HANDLE).